FDA Approves Prograf to Prevent Rejection of Heart Transplant Prograf |

« FDA Approvals - Cytogen Announces Submission of IND for CYT-500 for the Treatment | Main | FDA Approvals - Barr's Duramed Withdraws NDA for Lo SEASONALE(R) Extended-Cycle Oral Contraceptive »

FDA Approves Prograf to Prevent Rejection of Heart Transplant Prograf

FDA Approves Prograf to Prevent Rejection of Heart Transplant
Prograf offers an alternative to cyclosporine for use in certain combination immunosuppressive regimens in liver, kidney and heart transplantation.

Additional information in: Breaking News , FDA Recalls

FDA News Search

Get Legal Help

Breaking FDA Recalls

Breaking FDA Approvals

Health Tip

It’s a little known fact that coffee benefits your health in a variety of important ways .

Food & Drug Categories

FDA News Archive

Subscribe to this site's RSS feed
FDA Resources

FDA News Site Map
FDA Online Resources
FDA Related Resources